Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$770M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$580M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$391M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$322M |
| 5 |
UnitedHealth
UNH
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 3 |
RP
RealPage, Inc.
RP
|
+$316M |
| 4 |
Shopify
SHOP
|
+$312M |
| 5 |
Boeing
BA
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.82% |
| 2 | Healthcare | 7.16% |
| 3 | Financials | 5.78% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Industrials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISBC
4601
DELISTED
Investors Bancorp, Inc.
ISBC
| $1.02M | ﹤0.01% |
+71,515
| New | +$1.06M |
|
4602
PUT
Qorvo
QRVO
$7.99B
| $1.02M | ﹤0.01% |
5,200
+2,800
| +117% | +$516K |
|
4603
Neuronetics
STIM
$138M
| $1.02M | ﹤0.01% |
63,482
-251,437
| -80% | -$3.47M |
|
4604
Vera Bradley
VRA
$97M
| $1.02M | ﹤0.01% |
82,091
-81,727
| -50% | -$934K |
|
4605
Copart
CPRT
$27B
| $1.02M | ﹤0.01% |
30,832
-1,555,988
| -98% | -$48.2M |
|
4606
Standex International
SXI
$3.59B
| $1.01M | ﹤0.01% |
10,696
-10,914
| -51% | -$1.06M |
|
|
CONXU
4607
DELISTED
CONX Corp. Unit
CONXU
| $1.01M | ﹤0.01% |
100,000
| – | – |
|
|
NVO
4608
Novo Nordisk
NVO
$208B
| $1.01M | ﹤0.01% |
24,150
-678,668
| -97% | -$26.3M |
|
|
CCRD
4609
DELISTED
CoreCard
CCRD
| $1.01M | ﹤0.01% |
+32,116
| New | +$1.14M |
|
4610
CALL
Kohl's
KSS
$2.17B
| $1.01M | ﹤0.01% |
18,300
+13,700
| +298% | +$788K |
|
|
SFE
4611
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.01M | ﹤0.01% |
+130,032
| New | +$887K |
|
4612
Rockwell Medical
RMTI
$28.4M
| $1.01M | ﹤0.01% |
+10,071
| New | +$1.04M |
|
|
NAGE
4613
Niagen Bioscience
NAGE
$271M
| $1.01M | ﹤0.01% |
102,218
-806,695
| -89% | -$7.03M |
|
|
GBIO
4614
DELISTED
Generation Bio
GBIO
| $1.01M | ﹤0.01% |
+3,744
| New | +$1.12M |
|
4615
KB Financial Group
KB
$41.4B
| $1M | ﹤0.01% |
+20,390
| New | +$1.02M |
|
|
TUEM
4616
DELISTED
Tuesday Morning Corp
TUEM
| $1M | ﹤0.01% |
+7,443
| New | +$995K |
|
4617
Akebia Therapeutics
AKBA
$354M
| $1M | ﹤0.01% |
264,954
-1,083,339
| -80% | -$3.65M |
|
4618
Caesarstone
CSTE
$72.3M
| $1M | ﹤0.01% |
68,000
-58,485
| -46% | -$884K |
|
4619
PVH
PVH
$4B
| $1M | ﹤0.01% |
9,321
-27,475
| -75% | -$3.02M |
|
4620
Citizens Financial Group
CFG
$30.3B
| $1M | ﹤0.01% |
21,824
-1,010,788
| -98% | -$47.7M |
|
4621
Champion Homes
SKY
$4.37B
| $1M | ﹤0.01% |
18,775
+6,849
| +57% | +$323K |
|
4622
TransAlta
TAC
$3.95B
| $1M | ﹤0.01% |
100,260
+66,383
| +196% | +$641K |
|
|
STSA
4623
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1M | ﹤0.01% |
141,783
+126,853
| +850% | +$684K |
|
|
CZOO
4624
CALL
DELISTED
Cazoo Group Ltd
CZOO
| $999K | ﹤0.01% |
267
-28
| -9% | -$559K |
|
4625
GH Research
GHRS
$1.93B
| $997K | ﹤0.01% |
+45,866
| New | +$937K |
|
Similar funds
Millennium Management's Q2 2021 Portfolio in Review
As of Q2 2021, Millennium Management held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $13.3B of net new capital in Q2 2021, opening 1,693 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.
- Millennium Management's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
- Millennium Management added most to Linde in Q2 2021, an estimated $770M increase.
- Millennium Management's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
- Millennium Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
- Millennium Management's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
- Millennium Management opened 1,693 new positions and closed 1,074 in Q2 2021.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $163B.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.